We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of JAMA Neurology |

Highlights FREE

JAMA Neurol. 2016;73(5):493. doi:10.1001/jamaneurol.2015.2455.
Text Size: A A A
Published online


Munger et al examine whether serum 25-hydroxyvitamin D (25[OH]D) levels in early pregnancy are associated with risk of multiple sclerosis (MS) in offspring. Maternal serum 25(OH)D levels were measured using a chemiluminescence assay. The risk of MS among offspring and association with maternal 25(OH)D levels were the main outcomes. They find that insufficient maternal 25(OH)D during pregnancy may increase the risk of MS in offspring. Editorial perspective is provided by Benjamin M. Greenberg, MD, MHS.

Weintraub and coauthors determine whether antipsychotic (AP) use in patients with Parkinson disease (PD) is associated with increased mortality. The rates of 180-day mortality were compared in 7877 patients initiating AP therapy and 7877 patients who did not initiate AP therapy (matched for age ±2.5 years, sex, race, index year, presence and duration of dementia, PD duration, delirium, hospitalization, Charlson Comorbidity Index, and new nonpsychiatric medications). They show that use of APs is associated with a significantly increased mortality risk in patients with PD, after adjusting for measurable confounders. Editorial perspective is provided by Mark S. Baron, MD.

Veenith and colleagues combine fluorine 18–labeled fluoromisonidazole and oxygen 15–labeled positron emission tomography to demonstrate the relative burden, distribution, and physiologic signatures of conventional macrovascular and microvascular ischemia in early traumatic brain injury (TBI). They estimated ischemic brain volume and hypoxic brain volume and compared their spatial distribution and physiologic signatures. They report that tissue hypoxia after TBI is not confined to regions with structural abnormality and can occur in the absence of conventional macrovascular ischemia. This physiologic signature is consistent with microvascular ischemia and is a target for novel neuroprotective strategies. Editorial perspective is provided by Paul M. Vespa, MD.

Tarawneh and colleagues investigate the diagnostic and prognostic utility of cerebrospinal fluid (CSF) neurogranin levels in a large, well-characterized cohort of individuals with symptomatic Alzheimer disease (AD) and cognitively normal controls. They provide correlations between baseline CSF biomarker levels and future cognitive decline in patients with symptomatic AD and cognitively normal controls over time. They report that CSF neurogranin complements the collective ability of these markers to predict future cognitive decline in cognitively normal individuals and, therefore, will be a useful addition to the current panel of AD biomarkers. Editorial perspective is provided by Steven T. DeKosky, MD, and Todd Golde, MD, PhD.




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.